Eyeworld Daily News

4 | EYEWORLD DAILY NEWS | MAY 6, 2023 ASCRS ANNUAL MEETING DAILY NEWS importance of a gas permeable lens over refraction. Besides optimizing in the clinic, we need to optimize in the surgery, he said. Dr. Thompson went on to touch on the use of the femtosecond laser. "I'm a big believer in the automat- ed capsulotomy," Dr. Thompson said, but he said he wasn't going to debate about what's better between manual, femtosecond laser, or Zepto (Centricity Vision). He mentioned a study that measured patient satis- faction and induction of internal comma. He noted a study on refrac- tive outcomes where there was no difference between femtosecond laser and traditional cataract surgery, but Dr. Thompson thinks there are other ways to "peel back the onion." We must look at things like capsular overlap rate and induced HOAs, he said. As we minimize other sources of aberrations and we really want the patient to neuroadapt beautifully, we want to remember the power of neuroadaptation, he said. If you can think of it as a one-year journey, you will be happy, he said. Even though I tell them all about the one-year journey, he said, I also have our team call them at one month. There are a lot of patient personalities, and they don't always remember what you told them in the clinic. "What I present is a recipe to realize that what we can do with presbyopia implants is amazing," Dr. Thompson said. Editors' note: Dr. Thompson has finan- cial interests with a variety of ophthal- mic companies. "I think of myself as a physician who is an ophthalmologist and at his core is a refractive surgeon," he said. I think we're thinking about uncorrected and best corrected visual acuity but ultimately also need to be thinking about where we're leav- ing the patient's uncorrected and best-corrected image quality. I know, if I'm a patient, I want to be able to see well and crisply, he said. He highlighted his research journey and discussed his work with phakic IOLs, presbyopia-correcting technology, and more. He realized that refractive surgery was moving towards the lens and wanted to think about how to become a comprehen- sive refractive surgeon. Dr. Thompson also discussed his participation in clinical trials for tri- focal lenses. He remembered 99.2% of patients in a trifocal study said they would choose that option again and would recommend it. The Light Adjustable Lens (RxSight) was an- other trial that Dr. Thompson noted his involvement in. I want to thank industry for what they've done for research and devel- opment and to bring the diagnostics and implants and help us create what we call premium cataract surgery, he said. Dr. Thompson discussed the pressures holding back premium cataract practices, and particularly getting involved with presbyopia-cor- recting technology. I believe the pressure is surgeon confidence, he said, noting the need to teach new users to get involved in new technol- ogies. The most powerful thing that has led to growth of our seven centers in upper Midwest is how we love and care for each other and our patients, he said. "I teach whole-day courses on how to create a team culture." This culture is important for the pre- mium cataract surgeon. Surgeon confidence needs to include an understanding of dys- photopsias, Dr. Thompson said. You can measure and evaluate a number of other factors as well, he said, mentioning the tear film, epitheli- um, anterior stroma, IOLs, posterior capsule, and the vitreous. We have old technologies and tests that can still help us, Dr. Thompson said, stressing the continued from page 1 Thank you, Operation Sight volunteers Stop by the ASCRS Foundation booth in the Sails Pavilion to pick up your complimentary scrub cap.

• Cover